Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

09bcf721-e54b-49d6-8668-a9c8a49d7177 - samples

ABSTRACT: Whole-genome sequencing of 135 tumor samples and 98 normal samples of gastric cancer with peritoneal metastasis

PROVIDER: EGAD00001006963 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

RNA sequence of gastric cancer with malignant ascites [RNA-seq]

Project description:Gastric cancer is one of the leading causes of cancer mortality worldwide, and peritoneal metastasis is a hallmark of incurable advanced gastric cancer. The identification of molecular vulnerability for such conditions is imperative to improve the prognosis of gastric cancer. Here, we comprehensively analysed cancer cells purified from malignant ascitic fluid samples and their corresponding cell lines from 98 patients, through whole-genome sequencing, whole transcriptome sequencing, methylation analyses, and genome-wide enhancer analyses.

2021-05-21 | GSE162214 | GEO

Genome-wide maps of chromatin state in gastric cancer with malignant ascites [ChIP-seq]

2021-05-21 | GSE162213 | GEO

Methylation profiling in gastric cancer with malignant ascites.

2021-05-21 | GSE168999 | GEO

Gastric carcinoma patients and healthy subjects

Project description:Gastric cancer is one of the most aggressive cancers and is the second leading cause of cancer death worldwide. Approximately 40% of global gastric cancer cases occur in China, with peritoneal metastasis being the prevalent form of recurrence and metastasis in advanced disease (>50%). Currently, there are limited clinical approaches for predicting and treatment of peritoneal metastasis, resulting in a 6- month average survival time. By comprehensive genome analysis will uncover the pathogenesis of peritoneal metastasis. Here we describe a comprehensive whole-genome and transcriptome sequencing analysis of one advanced gastric cancer case, including non-cancerous mucosa, primary cancer and matched peritoneal metastatic cancer. The peripheral blood is used as normal control.

2019-06-12 | GSE64916 | GEO

Genome-wide analysis of long noncoding RNA expression profile in gastric cancer peritoneal metastasis

Project description:Gastric cancer (GC) remains one of the most prevalent tumor worldwide, and ranks third in cancer-related deaths globally. Long non-coding RNAs (lncRNAs) have been reported to play significant role in the progression and metastasis in gastric cancer (GC), however, the molecular mechanism are largely elusive. We aim to identify up-regulated lncRNA in gastric cancer peritoneal metastasis and study their function in promoting tumor progression and metastasis.

2025-04-01 | GSE200697 | GEO

In vitro and In vivo Evidence of Long Non-coding OR3A4 in Gastric Cancer Progression and Tumorigenicity

Project description:LncRNA and mRNA expression profiling for 7 human gastric cancr samples (3 tumor tissues and 3 tumor lymph node and 1 normal tissue) We have completed the metastasis-related Long Noncoding RNA expression profiling data microarray analysis of the 7 human gastric cancer related samples

2014-02-11 | GSE54835 | GEO

GCP study

Project description:Genome sequencing data of gastric cancer with peritoneal metastasis.

| EGAS00001004959 | EGA

Single-cell sequencing technology reveals the characteristics of the tumor microenvironment in gastric cancer and its peritoneal metastases

Project description:To analyze the tumor microenvironment characteristics of gastric cancer and its peritoneal metastases, we collected fresh surgical specimens pathologically confirmed as gastric cancer and peritoneal metastases, and performed single-cell sequencing.

2026-01-14 | GSE308231 | GEO

Divergent clonal evolution and tumor microenvironment remodeling shape gastric cancer peritoneal metastasis

Project description:Gastric cancer peritoneal metastasis (GCPM) is a distinct clinical entity with a poor prognosis, characterized by aggressive features and limited treatment options. Understanding its molecular biology is critical for developing effective therapies. We performed whole genome and transcriptome sequencing on GCPM samples and paired primary gastric cancer (GC) tissues from 14 and 26 patients, respectively. Our analysis revealed substantial intra-patient heterogeneity between GCPM and primary tumors at both genetic and functional levels. Inter-patient variability was observed in mutational overlaps, with some signatures unique to either GCPM or primary tumors. Tumor evolution analysis suggested divergent clonal evolution, with distinct clones specific to GCPM or primary tumors in most patients. The tumor microenvironment (TME) was poorly conserved between primary GC and GCPM, with desert-type primary tumors often transitioning to immune-enriched TMEs in metastases. These findings suggest that immunotherapy resistance in GCPM may arise from factors beyond intrinsic TME characteristics, such as limited drug delivery due to the peritoneal-plasma barrier. Collectively, our results highlight significant molecular and TME heterogeneity between GCPM and primary tumors, emphasizing the need for GCPM-specific stratification and innovative treatment strategies to improve outcomes.

2026-02-23 | GSE314812 | GEO

Project description:Divergent clonal evolution and tumor microenvironment remodeling shape gastric cancer peritoneal metastasis

| PRJNA1428870 | ENA